SCHEMBL5481371

SCHEMBL5481371

COc1ccc(-c2nccc(N)c2C#N)c(OC)c1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.45
KDM4E B2RXH2 3/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
USP8 P40818 1/20 0.40
USP7 Q93009 1/20 0.40
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39
ALDH1A1 P00352 3/20 0.38
HTT P42858 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 2/20 0.38
PRKCZ Q05513 1/20 0.36
MEN1 O00255 1/20 0.36
GLA P06280 1/20 0.36
GFER P55789 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5480716 0.81 ADORA2A (0.56) KDM4EL3MBTL1HPGDSMN1; SMN2ADORA2A
SCHEMBL5481379 0.80 KDM4E (0.46) MAPK1KDM4EL3MBTL1HPGDSMN1; SMN2
SCHEMBL10757785 0.74 ALDH1A1 (0.46) MAPK1KDM4EL3MBTL1HPGDSMN1; SMN2
SCHEMBL5482010 0.70 LMNA (0.56) KDM4EHPGDSMN1; SMN2USP8ADORA2A
SCHEMBL31728806 0.70 ALDH1A1 (0.45) MAPK1KDM4EL3MBTL1HPGDADORA1
SCHEMBL5483595 0.68 ALDH1A1 (0.45) MAPK1KDM4EL3MBTL1HPGDADORA2A
SCHEMBL18005940 0.67 MAPK1 (0.43) MAPK1KDM4EL3MBTL1HPGDSMN1; SMN2
SCHEMBL564697 0.66 ALDH1A1 (0.53) MAPK1KDM4EL3MBTL1HPGDALDH1A1
SCHEMBL29539340 0.66 PLA2G2A (0.37) MAPK1KDM4EUSP8USP7ADORA2A
SCHEMBL642228 0.66 HDAC4 (0.58) MAPK1KDM4EHPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors WYETH 2007-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070287738-A1 Substituted Cyanopyridines as protein kinase inhibitors CNKSR1, MAP3K1, MAP3K6 MAPK1 28/4885KDM4E 959/4885L3MBTL1 2767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.